Noerr has advised Veolia group on the purchase of Nuon Energie und Service GmbH. A team from Noerr’s Energy Group led by the Berlin partners Dr. Tibor Fedke and Dr. Christoph Spiering, and the Düsseldorf real estate specialist Christoph Brenzinger acted for Veolia.
A Heuking team led by Munich-based M&A partner Boris Dürr GmbH advised Solarpark Blautal GmbH on the acquisition of 80 percent of centrotherm photovoltaics AG. The purchase price was not disclosed. In addition to the purchase of the share package, centrotherm photovoltaics AG concluded a financing agreement that secures the company’s funding.
The China National Chemical Corporation, one of China's largest chemical companies, has signed an agreement to purchase the KraussMaffei Group, a German manufacturer of machines for plastic part production. The transaction still has to be approved by the competent authorities.
Bär & Karrer is advising China National Chemical Corporation on the Swiss angle of the transaction. The Bär & Karrer team includes Christoph Neeracher, Philippe Seiler, Beda Kaufmann (all M&A), Corrado Rampini (Real Estate) and Ruth Bloch-Riemer (Social Security & Pensions).
The CMS International Private Equity team, together with CMS teams in Slovenia, Serbia and other jurisdictions, advised Polish private equity fund Innova Capital on the acquisition of the Slovenian Trimo Group, a leading European provider of complete solutions for building envelopes and steel facade systems. The sellers are nine banks, including Slovenia's largest bank Nova Ljubljanska Banka (NLB). The transaction is subject to merger control approvals and is scheduled to close in Q1 2016, once conditions precedent have been fulfilled.
Simmons & Simmons has advised RCMA Group on its acquisition of the UK cotton trading business of Liverpool-headquartered company Plexus Cotton.
RCMA Group is a Singapore-based commodities trader which specialises in rubber, cotton, sugar, coffee and energy. The acquisition of Plexus’ business further enhances RCMA Group’s commodities business.
DLA Piper represented NuVasive, Inc. in connection with its acquisition of Ellipse Technologies, a medical technology company focused on revolutionizing procedural solutions for complex skeletal deformity. The deal was announced January 5, 2016, and consists of a US$380 million upfront cash payment and a potential $30 million milestone payable in 2017 related to the achievement of specific revenue targets.
Tech Mahindra Limited, part of India-based Mahindra Group, and Mahindra & Mahindra jointly entered into an agreement with Pincar S.r.l. to purchase a controlling stake in Italian Pininfarina.
Under the lead of Italian law firm Gianni Origoni Grippo Capelli, Rome, Heuking Kühn Lüer Wojtek advised Mahindra Group and accompanied the German part of the transaction.
Mayer Brown announced today that it represented the Publicis group on the squeeze-out of minority shareholders of Pixelpark AG. The resolution was approved in Pixelpark AG´s shareholders’ meeting in November 2015 and was recorded in the commercial register at the end of December.
Publicis group is a global advertising company with locations in 108 countries and more than 76,000 employees.
The Publicis inhouse team included Dr. Maik W. Fettes (Legal Director) and Nadine Säuberlich, LLM (Legal Counsel, Corporate).
On 9 December 2015, Swiss Automotive Group AG (SAG), one of the largest suppliers of spare car parts in Europe, entered into an agreement regarding the acquisition of a stake in Autonet, a group mainly active in Romania and Hungary.
Lenz & Staehelin advised SAG in this transaction. The Team was led by Jacques Iffland and Simone Ehrsam (Corporate). Romain Herzog (Corporate) and Adrien Alberini (Competition) also participated.
Noerr has advised the US healthcare company MediBeacon on its acquisition of the German company Mannheim Pharma & Diagnostics, a life science company specialising in animal diagnostics.
Mannheim Pharma & Diagnostics owns a technology for measuring renal function in animals, which supplements MediBeacon’s IP portfolio. MediBeacon’s development activities focus on a system for monitoring human renal function, which is currently undergoing clinical tests. It enables physicians to constantly monitor patients’ renal function in real time.